Lung Cancer Foundation

 click on photo above for link.

5,000 - screen-print stickers on clear vinyl at  3.36625" x 4"

5,000 - screen-print stickers on white vinyl at 2.71" x 3"

Thank you to everyone at The Bonnie J. Addario Lung Cancer Foundation, for your order. Please visit the site to see how you can help!

About

The Bonnie J. Addario Lung Cancer Foundation (BJALCF) was founded with one diagnosis, long before its official start date, when Bonnie’s life was redefined. Bonnie’s prognosis was grim when she was diagnosed with Lung Cancer in 2004. But following a 17-hour surgery, a battery of nurses and physicians, an army of radiation and chemotherapy treatments, blood clots, procedures and tubes that invaded her formerly predictable life, Bonnie became a Lung Cancer survivor.  She realized that she was in a unique position to be the voice that could be heard throughout the world for the other 1.5 million people personally affected by the #1 cancer killer – Lung Cancer. She began to think of ways to help others facing the crisis of this highly stigmatized disease. What about the 450 other patients who die a day of Lung Cancer in the U.S. alone, and their families, Bonnie asked. Where’s the outrage? The morning the news broke that Dana Reeve lost her battle with Lung Cancer, Bonnie decided:  “Enough was enough!” BLALCF was born as a 501(c)3 on the afternoon of March 6, 2006. The original plan was to hold a few galas and golf tournaments and donate the proceeds to the University of California in San Francisco (UCSF). But, quickly, Bonnie and her backers realized that wasn’t enough. Bonnie committed herself along with her family and friends to MAKE LUNG CANCER MATTER, TOO!

Today, BJALCF has grown into the first international collaborative entity of its kind, raising over $4 million in its first four years. Now, it hopes to become the global leader in the Lung Cancer movement. Two years after BJALCF began, the Addario Lung Cancer Medical Institute (ALCMI) was created as a spin-off to connect the top thought leaders, scientists, researchers, and physicians worldwide to lead and empower patients toward better treatment options. Only immediate results-oriented projects or programs promising to catalyze progress through early detection, genetic testing, drug discovery and patient-focused outcomes are considered. The ultimate goal of BJALCF is to increase the inexcusably low survival rate of Lung Cancer by becoming the largest source of non-profit funding dedicated to turning Lung Cancer into a manageable chronic disease in Bonnie’s lifetime.

No one survives the crisis of Lung Cancer without a worldwide web of people and the most up-to-date treatment. There is no better place to funnel research dollars than to BJALCF and its multitude of collaborators and programs, including ALCMI, when it comes to the pursuit of extending and enhancing the lives of patients and families with Lung Cancer.  We are in a hurry.  Hurry with us.